RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
https://doi.org/10.20996/1819-6446-2007-3-4-58-60
Abstract
Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction.
About the Authors
I. V. Szirov
Moscow State Medial Stomatological University
Russian Federation
Russian Federation
E. V. Malichenko
Moscow State Medial Stomatological University
Russian Federation
Russian Federation
References
1. Mancia G. Blood pressure variability: mechanisms and clinical significance. J Cardiovasc Pharmacol 1990;16 Suppl 6:S1-6.
2. Pfeffer MA, Pfeffer JM. Reversing cardiac hypertrophy in hypertension. N Engl J Med 1990;322:1388-90.
3. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-41.
4. Недогода С.В., Сергеев В.С., Брель У.А. Зофеноприл при артериальной гипертензии – один из многих или не равный многим? Consilium Medicum 2005;7(11):893-6.
5. Subissi A, Evangelista S, Giachetti A. Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar cardioprotective properties. Cardiovasc Drug Rev 1999;17:115-33.
6. Преображенский Д.В., Сидоренко Б.А., Першуков И.В. и др. Ингибиторы ангиотензинпревращающего фермента в остром периоде инфаркта миокарда: место зофеноприла. Кардиология 2006;46(5):89-95.
7. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 1993;342:821-8.
8. Hall AS, Murray GD, Ball SG. Follow-up study of patients randomly allocated to ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. Lancet 1997;349:1493-7.
9. Van de Werf F, Ardissino D, Betriu A, et al. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
10. Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 2004;141(2):102-12.
Review
For citations:
Szirov I.V., Malichenko E.V. RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION. Rational Pharmacotherapy in Cardiology. 2007;3(4):58-60. (In Russ.) https://doi.org/10.20996/1819-6446-2007-3-4-58-60
Views:
2240
.jpg)
Email this article 